López-Carrera I, Durán-McKinster C, Sáez-de-Ocariz MM, Orozco-Covarrubias L, Palacios-López C, Ruiz-Maldonado R

Language: Spanish
References: 18
Page: 289-294
PDF size: 433.63 Kb.

ABSTRACT

Background: Pityriasis rosea is an acute disseminated rash of unknown etiology and prolonged duration, characterized by erythematoussquamous plaques. Despite having an ostentatious clinical picture for both the patient and family, it is self-limited and usually resolves without sequelae. Pityriasis rosea is often erroneously diagnosed as mycosis and given unnecessary treatment.
Objective: To describe the clinical and demographical features of pityriasis rosea in a group of Mexican pediatric patients.
Patients and methods: Retrospective and descriptive study in which the clinical and demographic features of patients attended at the department of dermatology of the National Institute of Pediatrics with diagnosis of pityriasis rosea within a ten year period were analysed.
Results: Thirty patients with pityriasis rosea, with a frequency of 3.6 per 1000 dermatological patients. Pityriasis rosea was more frequent in females with a ratio of 1.5 to 1 and a mean age of 10 years. More than half of the patients (56%) had an atypical presentation, and biopsy was mandatory in 7 patients to establish the final diagnosis.
Conclusions: The knowledge of the clinical features of pityriasis rosea by primary care physicians will prevent from unnecessary work-up and treatments.

REFERENCES

1. Percival GH. Pityriasis rosea. Br J Dermatol 1932;44:241-53.

2. Chuang TY, Ilstrup DM, Perry HO, Kurland LT. Pityriasis rosea in Rochester, Minnesota 1969-78. J Am Acad Dermatol 1982;7:80-89.

3. Ozge G, Siebel E, Aysen K. Childhood Pityriasis Rosea. Ped Dermatol 2009;26:750-51.

4. González LM, Allen R, Janniger CK, Schwartz RA. Pityriasis rosea: An important papuloscamous disorder. Int J of Dermatol 2005;44;757-64.

5. Drago F, Broccolo F, Rebora A. Pityriasis rosea: An update with a critical appraisal of its possible herpes viral etiology. J Am Acad 2009;61(2):303-18.

6. Hendricks AA, Lohr JA. Pityriasis rosea in infancy. Arch Dermatol 1979;115:896-7.

7. Casani C. Pitiriasis Rosada Recurrente. Rev Pediatr Aten Primaria. 2006;8(6):15-9.

8. Rebora A, Drago F, Broccolo F. Pityriasis rosea and herpes viruses: Facts and controversies. Clin in Dematology 2010;28:497-501.

9. Kwon NH, Kim JE, Cho BK, Park HJ. A novel influenza a (H1N1) virus as a possible cause of pityriasis rosea? JEADV 2011;25:368-69.

10. Chuh AA, Chan HH. Prospective case-control study of Chlamydia, legionella and mycoplasma infections in patients with pityriasis rosea. Eur J Dermatol 2002;11:170-3.

11. Niles HD, Klumpp MM. Pityriasis rosea: Review of the literature and report of two hundred and nineteen cases, in thirty eight of which convalescent serum was used. Arch Dermatol Syphilol 1940;41:265-94.

12. Bjornberg A, Hellgren L. Pityriasis rosea: a statistical, clinical, and laboratory investigation of 826 patients and matched healthy controls. Acta Derm Venereol 1962;42(Suppl):1-68.

13. Wollenberg A, Eames T. Skin Diseases following a christmas tree pattern. Clin in Dermatology 2011;29:189-94.

14. Vidimos AT, Camisa C. Tongue and cheek: oral lesions in pityriasis rosea. Cutis 1992;50:276-80.

15. Ackerman AB. Histologic Diagnosis of inflammatory Skin Disease: a Method By Pattern Analysis. Philadelphia: 3rd edition; 1978:233-35.

16. Goens JL, Janniger CK, De Wolf K. Dermatologist and sytemic manifestations of syphilis. Am Fam Physician 1994;50:1013-1020.

17. Chuh AA, Dofitas BL, Comisel GG, Reveiz L, Sharma V, et al. Interventions for pityriasis rosea. Cochrane Database Syst Rev 2:CD005068 (2007).

18. Sharma PK, Yadav TP, Gautam RK, Taneja N, Satyanarayana L. Erythromicin in pityriasis rosea: a double-blind, placebocontrolled clinical trial. J Am Acad Dermatol 2000;42:241- 244.